000 03768nam a22005055i 4500
001 978-90-481-3040-5
003 DE-He213
005 20140220084556.0
007 cr nn 008mamaa
008 100301s2010 ne | s |||| 0|eng d
020 _a9789048130405
_9978-90-481-3040-5
024 7 _a10.1007/978-90-481-3040-5
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
100 1 _aDittmar, Thomas.
_eeditor.
245 1 0 _aStem Cell Biology in Health and Disease
_h[electronic resource] /
_cedited by Thomas Dittmar, Kurt S. Zanker.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2010.
300 _aXII, 426p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aBone marrow-derived stem cells -- Hematopoietic Stem and Progenitor Cells in Clinical Use – Transplantation and Mobilization -- Ex Vivo Expansion of HSPCs -- Modulation of Hematopoietic Stem/Progenitor Cell Migration -- Properties of Mesenchymal Stem Cells to Consider for Cancer Cell Therapy -- Embryonic Stem Cells -- Alternative Embryonic Stem Cell Sources -- Cell Therapy in Parkinson’s Disease -- Transplantation of Stem Cells and Their Derivatives in the Treatment of Multiple Sclerosis -- Cancer Stem Cells -- Cancer: A Stem Cell-based Disease? -- Stem Cell Niche Versus Cancer Stem Cell Niche – Differences and Similarities -- The Chronically Inflamed Microenvironment and Cancer Stem Cells -- Does the Chronically Inflamed Periodontium Harbour Cancer Stem Cells? -- Leukemia Stem Cells -- Cancer Stem Cells in Solid Tumors -- “One for All” or “All for One”? – The Necessity of Cancer Stem Cell Diversity in Metastasis Formation and Cancer Relapse -- Elimination of Cancer Stem Cells -- Potential Molecular Therapeutic Targets in Cancer Stem/Progenitor Cells: Are ATP-Binding Cassette Membrane Transporters Appropriate Targets to Eliminate Cancer-Initiating Cells?.
520 _aStem Cell Biology in Health and Disease presents an up-to-date overview about the dual role of stem cells in health and disease. The Editors have drawn together an international team of experts providing chapters which, in this fully-illustrated volume, discuss: - the controversial debate on the great expectations concerning stem cell based regeneration therapies raised by the pluripotency of various stem cells. - the advantages and concerns about embryonic stem cells (ES cells), induced pluripotent stem cells (iPS cells) and adult stem cells, such as bone marrow-derived stem cells (BMDCs). - the type of stem cells, which has become of interest in the past decade, namely so-called cancer stem cells (CSCs). CSCs are now in the focus of cancer research since the eradication of tumour initiating cells would raise the changes of definitely cure cancer. Professor Dittmar and Professor Zänker have edited a must-read book for researchers and professionals working in the field of regenerative medicine and/or cancer.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aImmunology.
650 0 _aTransplantation of organs, tissues, etc.
650 0 _aStem cells.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aOncology.
650 2 4 _aStem Cells.
650 2 4 _aImmunology.
650 2 4 _aTransplant Surgery.
700 1 _aZanker, Kurt S.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789048130399
856 4 0 _uhttp://dx.doi.org/10.1007/978-90-481-3040-5
912 _aZDB-2-SBL
999 _c113251
_d113251